Green Lantern #7 Cover B Evan Doc Shaner Card Stock Variant

Green Lantern #7 Cover B Evan Doc Shaner Card Stock Variant

NZD $13.95

THE DEATH OF A MAJOR GREEN LANTERN CHARACTER REVEALED! After his explosive confrontation with Sinestro, Green Lantern is confronted by the United Planets Lanterns for illegally operating within the quarantine zone, and the mystery of what took place on Korugar is finally revealed! PLUS: THE FINALE TO THE ORIGIN OF SINSON, AND THE LEAD-IN TO THE NEW SINISTER SONS SERIES!

Green Lantern #7 Cover B Evan Doc Shaner Card Stock Variant

Out Of Stock

FAQs on Green Lantern #7 Cover B Evan Doc Shaner Card Stock Variant

How much does "Green Lantern #7 Cover B Evan Doc Shaner Card Stock Variant" cost at Heroes for Sale?

The price of "Green Lantern #7 Cover B Evan Doc Shaner Card Stock Variant" at Heroes for Sale is NZD $13.95.

What brand is "Green Lantern #7 Cover B Evan Doc Shaner Card Stock Variant" associated with?

"Green Lantern #7 Cover B Evan Doc Shaner Card Stock Variant" is associated with the Green Lantern brand.

Who is the publisher of "Green Lantern #7 Cover B Evan Doc Shaner Card Stock Variant"?

The publisher of "Green Lantern #7 Cover B Evan Doc Shaner Card Stock Variant" is DC Entertainment.

What is the genre of "Green Lantern #7 Cover B Evan Doc Shaner Card Stock Variant"?

The genre of "Green Lantern #7 Cover B Evan Doc Shaner Card Stock Variant" is Superheroes.

What category does "Green Lantern #7 Cover B Evan Doc Shaner Card Stock Variant" fall under?

"Green Lantern #7 Cover B Evan Doc Shaner Card Stock Variant" falls under the category of Comics.

Who are the artists and cover artist of "Green Lantern #7 Cover B Evan Doc Shaner Card Stock Variant"?

The artists of "Green Lantern #7 Cover B Evan Doc Shaner Card Stock Variant" are Dale Eaglesham, and David Lafuente. The cover artist is Evan “Doc” Shaner.

Who are the writers of "Green Lantern #7 Cover B Evan Doc Shaner Card Stock Variant"?

The writers of "Green Lantern #7 Cover B Evan Doc Shaner Card Stock Variant" are Jeremy Adams, and Peter J. Tomasi.